Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Paperback. Etat : new. Paperback. Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied. These customized estimates can complement existing risk prediction tools and inform personalized decisions about the benefits and timing of LC screening in this potentially high-risk group. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9786189451192
Quantité disponible : 1 disponible(s)
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. N° de réf. du vendeur I-9786189451192
Quantité disponible : Plus de 20 disponibles
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand. N° de réf. du vendeur 407553028
Quantité disponible : 4 disponible(s)
Vendeur : Books Puddle, New York, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26406682587
Quantité disponible : 4 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. PRINT ON DEMAND. N° de réf. du vendeur 18406682577
Quantité disponible : 4 disponible(s)
Vendeur : AussieBookSeller, Truganina, VIC, Australie
Paperback. Etat : new. Paperback. Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied. These customized estimates can complement existing risk prediction tools and inform personalized decisions about the benefits and timing of LC screening in this potentially high-risk group. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. N° de réf. du vendeur 9786189451192
Quantité disponible : 1 disponible(s)
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied. These customized estimates can complement existing risk prediction tools and inform personalized decisions about the benefits and timing of LC screening in this potentially high-risk group. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9786189451192
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied. N° de réf. du vendeur 9786189451192
Quantité disponible : 2 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Life Expectancy In Cancer Survivors | Mohd Rashid | Taschenbuch | Englisch | 2026 | RASHID PUBLICATIONS | EAN 9786189451192 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. N° de réf. du vendeur 135472569
Quantité disponible : 5 disponible(s)